Immuneering (IMRX) Depreciation and Depletion (2020 - 2024)
Historic Depreciation and Depletion for Immuneering (IMRX) over the last 5 years, with Q4 2024 value amounting to $86116.0.
- Immuneering's Depreciation and Depletion fell 405.33% to $86116.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $355807.0, marking a year-over-year increase of 1021.98%. This contributed to the annual value of $355807.0 for FY2024, which is 1021.98% up from last year.
- Latest data reveals that Immuneering reported Depreciation and Depletion of $86116.0 as of Q4 2024, which was down 405.33% from $88949.0 recorded in Q3 2024.
- Immuneering's 5-year Depreciation and Depletion high stood at $90533.0 for Q2 2024, and its period low was $5656.0 during Q3 2020.
- For the 5-year period, Immuneering's Depreciation and Depletion averaged around $52121.7, with its median value being $68075.0 (2022).
- Per our database at Business Quant, Immuneering's Depreciation and Depletion soared by 46833.36% in 2022 and then tumbled by 405.33% in 2024.
- Immuneering's Depreciation and Depletion (Quarter) stood at $7449.0 in 2020, then soared by 98.89% to $14815.0 in 2021, then surged by 418.81% to $76862.0 in 2022, then rose by 16.77% to $89754.0 in 2023, then dropped by 4.05% to $86116.0 in 2024.
- Its last three reported values are $86116.0 in Q4 2024, $88949.0 for Q3 2024, and $90533.0 during Q2 2024.